Pediatric Sepsis Guidelines: Summary for resource-limited countries

Praveen Khilnani1, Sunit Singhi, Rakesh Lodha

  • 1IAP (Intensive Care Chapter), B42 Panchsheel enclave New Delhi 110017, India.

Insights

New pediatric sepsis guidelines offer practical, evidence-based recommendations for resource-limited settings like India and Africa. These guidelines address unique patient populations and limited resources, aiming to improve sepsis care globally.

Area of Science:

  • Pediatric critical care
  • Infectious diseases
  • Global health

Background:

  • Pediatric sepsis is a significant global health challenge.
  • Current sepsis guidelines are often designed for developed countries, with limited applicability in resource-limited nations like India and Africa.

Purpose of the Study:

  • To develop evidence-based clinical practice guidelines for pediatric sepsis tailored to resource-limited settings.
  • To achieve consensus among experts on feasible sepsis management strategies in India.

Main Methods:

  • An expert panel from the Indian Academy of Pediatrics (IAP) convened to discuss and formulate guidelines.
  • Discussions covered sepsis definitions, cardiopulmonary assessment, fluid therapy, inotropic support, mechanical ventilation, antibiotic therapy, and glycemic control.
  • Guidelines were developed considering the unique patient population and resource limitations in India.

Main Results:

  • Clinical practice guidelines for pediatric sepsis were formulated in text and flowchart formats.
  • The guidelines are specifically designed for resource-limited countries, including India and Africa.
  • Levels of evidence are indicated, and modifications are anticipated based on future data.

Conclusions:

  • The developed guidelines provide a framework for managing pediatric sepsis in resource-constrained environments.
  • Periodic review and revision (every 3-5 years) are planned to incorporate new evidence.
  • These guidelines aim to improve the delivery of early and effective care for pediatric sepsis in underserved regions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...